Variant · Snv
CEP89 NM_032816.5(CEP89):c.305G>A (p.Arg102Gln)
CI-VAR-00238973Explore in graph →p.Arg102GlnNM_032816.5:c.305G>AClinVar 1541372 rs73926195
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1541372 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Clear cell carcinoma of kidney; Hepatocellular carcinoma; Lung cancer; Sarcoma; Ovarian serous cystadenocarcinoma; Melanoma; Acute myeloid leukemia; Uterine corpus endometrial carcinoma; Malignant tumor of esophagus; Cervical cancer | germline | 3 | Feb 02, 2026 | clinvar |